Skip to content
PRCTPROCEPT BioRobotics Corp

Earnings

When PROCEPT BioRobotics Corp reports, what it reported each quarter, and how the stock took the results.

27 quarters. Mar 31, 2020 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Feb 24, after the close

Wed, Feb 24, 2027in 98 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 23 – Mar 25

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$76.38M
Revenue, change from a year earlier: Q3 2026 +18.0%, Q2 2026 +19.3%, Q1 2026 +20.2%, Q4 2025 +11.9%
Net income
-$29.85M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$98.29M+18.0% vs Q3 2025

Latest results

  1. Q3 2026Nov 4, 2026, after the closeThe release6.4%by the close of Nov 5
    Revenue
    $98.29M
    +18.0%
    Net income
    -$26.52M
    N/M
    EPS
    -$0.46
    N/M
    PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2026.
  2. Q2 2026Aug 4, 2026, after the closeThe release+5.7%by the close of Aug 5
    Revenue
    $94.50M
    +19.3%
    Net income
    -$26.86M
    N/M
    EPS
    -$0.47
    N/M
  3. Q1 2026Apr 29, 2026, after the closeThe release+10.7%by the close of Apr 30
    Revenue
    $83.13M
    +20.2%
    Net income
    -$31.64M
    N/M
    EPS
    -$0.56
    N/M
  4. Q4 2025Feb 25, 2026, after the closeThe release15.2%by the close of Feb 26
    Revenue
    $76.38M
    +11.9%
    Net income
    -$29.85M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 4, 2026 · after-hoursNov 4, 202635 d10-Q$98.29M+18.0%-$0.466.4%
Q2 2026Jun 30, 2026Aug 4, 2026 · after-hoursAug 5, 202636 d10-Q$94.50M+19.3%-$0.47+5.7%
Q1 2026Mar 31, 2026Apr 29, 2026 · after-hoursApr 30, 202630 d10-Q$83.13M+20.2%-$0.56+10.7%
FY 2025
Q4 2025derivedDec 31, 2025Feb 25, 2026 · after-hoursFeb 26, 202657 d10-K$76.38M+11.9%—15.2%
Q3 2025Sep 30, 2025Nov 4, 2025 · after-hoursNov 5, 202536 d10-Q$83.33M+42.8%-$0.389.8%
Q2 2025Jun 30, 2025Aug 6, 2025 · after-hoursAug 7, 202538 d10-Q$79.18M+48.4%-$0.3512.8%
Q1 2025Mar 31, 2025Apr 23, 2025 · after-hoursMay 2, 202532 d10-Q$69.16M+55.3%-$0.455.7%
FY 2024
Q4 2024derivedDec 31, 2024Feb 25, 2025 · after-hoursFeb 27, 202558 d10-K$68.24M+56.6%—+8.6%
Q3 2024Sep 30, 2024Oct 25, 2024 · after-hoursOct 28, 202428 d10-Q$58.37M+66.3%-$0.40+32.3%
Q2 2024Jun 30, 2024Aug 1, 2024 · after-hoursAug 2, 202433 d10-Q$53.35M+61.2%-$0.509.4%
Q1 2024Mar 31, 2024Apr 30, 2024 · after-hoursMay 2, 202432 d10-Q$44.54M+82.5%-$0.51—
Earlier years, FY 2020 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 4, 2026000039
10-QAug 5, 2026000030
10-QApr 30, 2026000022
10-KFeb 26, 2026000009
10-QNov 5, 2025000051
10-QAug 7, 2025000043
10-QMay 2, 2025000033
10-KFeb 27, 2025000007
10-QOct 28, 2024000030
10-QAug 2, 2024000020

Provenance

ProvenanceData status and checks

PROCEPT BioRobotics Corp · CIK 1588978 · Engraved from SEC EDGAR